Position in BIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$235,181
+$191,975 QoQ
Shares Held
801
+416.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#256
of 397 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MAI Capital Management holds $114,360,678 across 14 Medical Devices names. BIO ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
437,641 | $39,711,543 | |
| 2 | SYK |
Stryker Corp
|
114,533 | $36,059,569 | |
| 3 | BSX |
Boston Scientific Corp
|
519,011 | $22,151,389 | |
| 4 | MDT |
Medtronic plc
|
128,741 | $10,071,407 | |
| 5 | EW |
Edwards Lifesciences Corp
|
26,116 | $2,362,452 | |
| 6 | STE |
STERIS plc
|
4,786 | $1,007,787 | |
| 7 | PODD |
Insulet Corp
|
5,524 | $841,028 | |
| 8 | DXCM |
Dexcom Inc
|
9,049 | $609,450 |
All Filings in BIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,181 | 801 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $43,206 | 155 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,207 | 103 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,252 | 33 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $11,100 | 46 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,409 | 14 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,898 | 21 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||